Determinants of transstenotic gradients observed during angioplasty: an experimental model

Am J Cardiol. 1983 Dec 1;52(10):1311-7. doi: 10.1016/0002-9149(83)90594-5.

Abstract

Pressure gradient measurement across a stenosis is used during angioplasty to aid catheter positioning and estimate dilatation efficacy. The angioplasty catheter itself, however, further reduces lumen size, and therefore augments the transstenotic gradient. To more precisely define the catheter influence on gradient, we derived a theoretical expression relating the measured gradient with the angioplasty catheter in situ to the "true" gradient; that is, the gradient in the absence of the angioplasty catheter. We then tested this theoretical construct in a canine femoral artery angioplasty model. Fifty-four measurements were performed using 23 separate, 3-mm-long, 40 to 70% stenoses. As predicted by the theoretic model, "true" gradient is compounded by the angioplasty catheter principally as a function of the angioplasty catheter diameter (Dc) and the stenosis diameter (Ds). The best-fit curve of data points relating "true" and compounded gradients to various Dc and Ds combinations can be expressed as: Measured gradient = K X true gradient, where K = 0.25 (e)4.47 (Dc divided by Ds) and e = 2.718. Thus, the transstenotic gradient measured at angioplasty overestimates "true" resting gradient in a predictable manner, which is dependent on the ratio of Dc to Ds.

MeSH terms

  • Angioplasty, Balloon* / instrumentation
  • Animals
  • Blood Pressure Determination / methods
  • Blood Pressure*
  • Constriction, Pathologic
  • Coronary Disease / physiopathology
  • Coronary Disease / therapy
  • Disease Models, Animal
  • Dogs
  • Femoral Artery / physiopathology*
  • Humans
  • Mathematics